198 related articles for article (PubMed ID: 36958365)
1. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies.
Trickey A; Sabin CA; Burkholder G; Crane H; d'Arminio Monforte A; Egger M; Gill MJ; Grabar S; Guest JL; Jarrin I; Lampe FC; Obel N; Reyes JM; Stephan C; Sterling TR; Teira R; Touloumi G; Wasmuth JC; Wit F; Wittkop L; Zangerle R; Silverberg MJ; Justice A; Sterne JAC
Lancet HIV; 2023 May; 10(5):e295-e307. PubMed ID: 36958365
[TBL] [Abstract][Full Text] [Related]
2. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.
Antiretroviral Therapy Cohort Collaboration
Lancet HIV; 2017 Aug; 4(8):e349-e356. PubMed ID: 28501495
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies.
Trickey A; McGinnis K; Gill MJ; Abgrall S; Berenguer J; Wyen C; Hessamfar M; Reiss P; Kusejko K; Silverberg MJ; Imaz A; Teira R; d'Arminio Monforte A; Zangerle R; Guest JL; Papastamopoulos V; Crane H; Sterling TR; Grabar S; Ingle SM; Sterne JAC
Lancet HIV; 2024 Mar; 11(3):e176-e185. PubMed ID: 38280393
[TBL] [Abstract][Full Text] [Related]
4. Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study.
Smiley CL; Rebeiro PF; Cesar C; Belaunzaran-Zamudio PF; Crabtree-Ramirez B; Padgett D; Gotuzzo E; Cortes CP; Pape J; Veloso VG; McGowan CC; Castilho JL;
Lancet HIV; 2021 May; 8(5):e266-e273. PubMed ID: 33891877
[TBL] [Abstract][Full Text] [Related]
5. Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study.
Trickey A; Zhang L; Gill MJ; Bonnet F; Burkholder G; Castagna A; Cavassini M; Cichon P; Crane H; Domingo P; Grabar S; Guest J; Obel N; Psichogiou M; Rava M; Reiss P; Rentsch CT; Riera M; Schuettfort G; Silverberg MJ; Smith C; Stecher M; Sterling TR; Ingle SM; Sabin CA; Sterne JAC
Lancet HIV; 2022 Jun; 9(6):e404-e413. PubMed ID: 35659335
[TBL] [Abstract][Full Text] [Related]
6. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.
Johnson LF; Mossong J; Dorrington RE; Schomaker M; Hoffmann CJ; Keiser O; Fox MP; Wood R; Prozesky H; Giddy J; Garone DB; Cornell M; Egger M; Boulle A;
PLoS Med; 2013; 10(4):e1001418. PubMed ID: 23585736
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
Lodi S; Phillips A; Logan R; Olson A; Costagliola D; Abgrall S; van Sighem A; Reiss P; Miró JM; Ferrer E; Justice A; Gandhi N; Bucher HC; Furrer H; Moreno S; Monge S; Touloumi G; Pantazis N; Sterne J; Young JG; Meyer L; Seng R; Dabis F; Vandehende MA; Pérez-Hoyos S; Jarrín I; Jose S; Sabin C; Hernán MA;
Lancet HIV; 2015 Aug; 2(8):e335-43. PubMed ID: 26423376
[TBL] [Abstract][Full Text] [Related]
8. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.
Antiretroviral Therapy Cohort Collaboration
Lancet; 2008 Jul; 372(9635):293-9. PubMed ID: 18657708
[TBL] [Abstract][Full Text] [Related]
9. Life expectancy of people with HIV on antiretroviral therapy in Spain.
Jarrín I; Rava M; Del Romero Raposo J; Rivero A; Del Romero Guerrero J; De Lagarde M; Martínez Sanz J; Navarro G; Dalmau D; Blanco JR; Koerting A; Gomez Castell J; Del Amo J;
AIDS; 2024 Mar; 38(3):387-395. PubMed ID: 37905999
[TBL] [Abstract][Full Text] [Related]
10. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.
May MT; Gompels M; Delpech V; Porter K; Orkin C; Kegg S; Hay P; Johnson M; Palfreeman A; Gilson R; Chadwick D; Martin F; Hill T; Walsh J; Post F; Fisher M; Ainsworth J; Jose S; Leen C; Nelson M; Anderson J; Sabin C;
AIDS; 2014 May; 28(8):1193-202. PubMed ID: 24556869
[TBL] [Abstract][Full Text] [Related]
11. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.
Boulle A; Schomaker M; May MT; Hogg RS; Shepherd BE; Monge S; Keiser O; Lampe FC; Giddy J; Ndirangu J; Garone D; Fox M; Ingle SM; Reiss P; Dabis F; Costagliola D; Castagna A; Ehren K; Campbell C; Gill MJ; Saag M; Justice AC; Guest J; Crane HM; Egger M; Sterne JA
PLoS Med; 2014 Sep; 11(9):e1001718. PubMed ID: 25203931
[TBL] [Abstract][Full Text] [Related]
12. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.
; Lodwick RK; Sabin CA; Porter K; Ledergerber B; van Sighem A; Cozzi-Lepri A; Khaykin P; Mocroft A; Jacobson L; De Wit S; Obel N; Castagna A; Wasmuth JC; Gill J; Klein MB; Gange S; Riera M; Mussini C; Gutiérrez F; Touloumi G; Carrieri P; Guest JL; Brockmeyer NH; Phillips AN
Lancet; 2010 Jul; 376(9738):340-5. PubMed ID: 20638118
[TBL] [Abstract][Full Text] [Related]
13. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.
; Zwahlen M; Harris R; May M; Hogg R; Costagliola D; de Wolf F; Gill J; Fätkenheuer G; Lewden C; Saag M; Staszewski S; d'Arminio Monforte A; Casabona J; Lampe F; Justice A; von Wyl V; Egger M
Int J Epidemiol; 2009 Dec; 38(6):1624-33. PubMed ID: 19820106
[TBL] [Abstract][Full Text] [Related]
14. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
[TBL] [Abstract][Full Text] [Related]
15. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.
Molina JM; Grund B; Gordin F; Williams I; Schechter M; Losso M; Law M; Ekong E; Mwelase N; Skoutelis A; Wiselka MJ; Vandekerckhove L; Benfield T; Munroe D; Lundgren JD; Neaton JD;
Lancet HIV; 2018 Apr; 5(4):e172-e180. PubMed ID: 29352723
[TBL] [Abstract][Full Text] [Related]
16. Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.
Cornell M; Johnson LF; Schomaker M; Tanser F; Maskew M; Wood R; Prozesky H; Giddy J; Stinson K; Egger M; Boulle A; Myer L;
Lancet HIV; 2015 Sep; 2(9):e368-75. PubMed ID: 26423550
[TBL] [Abstract][Full Text] [Related]
17. Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study.
May MT; Vehreschild JJ; Trickey A; Obel N; Reiss P; Bonnet F; Mary-Krause M; Samji H; Cavassini M; Gill MJ; Shepherd LC; Crane HM; d'Arminio Monforte A; Burkholder GA; Johnson MM; Sobrino-Vegas P; Domingo P; Zangerle R; Justice AC; Sterling TR; Miró JM; Sterne JAC; ; Boulle A; Stephan C; Miro JM; Cavassini M; Chêne G; Costagliola D; Dabis F; Monforte AD; Del Amo J; Van Sighem A; Fätkenheuer G; Gill J; Guest J; Haerry DH; Hogg R; Justice A; Shepherd L; Obel N; Crane H; Smith C; Reiss P; Saag M; Sterling T; Teira R; Williams M; Zangerle R; Sterne J; May M; Ingle S; Trickey A
Clin Infect Dis; 2016 Jun; 62(12):1571-1577. PubMed ID: 27025828
[TBL] [Abstract][Full Text] [Related]
18. Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study.
O'Connor J; Smith C; Lampe FC; Johnson MA; Chadwick DR; Nelson M; Dunn D; Winston A; Post FA; Sabin C; Phillips AN;
Lancet HIV; 2017 Jul; 4(7):e295-e302. PubMed ID: 28479492
[TBL] [Abstract][Full Text] [Related]
19. HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.
May MT; Sterne JA; Costagliola D; Sabin CA; Phillips AN; Justice AC; Dabis F; Gill J; Lundgren J; Hogg RS; de Wolf F; Fätkenheuer G; Staszewski S; d'Arminio Monforte A; Egger M;
Lancet; 2006 Aug; 368(9534):451-8. PubMed ID: 16890831
[TBL] [Abstract][Full Text] [Related]
20. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.
Helleberg M; May MT; Ingle SM; Dabis F; Reiss P; Fätkenheuer G; Costagliola D; d'Arminio A; Cavassini M; Smith C; Justice AC; Gill J; Sterne JA; Obel N
AIDS; 2015 Jan; 29(2):221-9. PubMed ID: 25426809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
